-
-
-
-
-
-
-
After-hours movers: Netflix, Alcoa, Knight-Swift, NiSource
-
-
-
-
-
-
-
Trevi Therapeutics schedules FDA meeting for chronic cough drug program
-
-
-
-
-
-
-
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025
-
-
-
-
-
-
-
Trevi Therapeutics Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
-
-
-
-
-
-
-
Trevi Therapeutics to Report Fourth Quarter and Year End 2024 Financial Results and Provide a Corporate Update on March 18, 2025
-
-
-
-
-
-
-
Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024
-
-
-
-
-
-
-
Trevi Therapeutics (TRVI) Misses Q1 EPS by 2c
-
1,216,204 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

